you are leaving Destracapital.com

It is important to note that by clicking on this link you will be leaving this website and any information viewed there is not the property of Destra Capital Investments LLC.

 

Strategies

Destra represents an array of investment products including Mutual Funds, Closed-End Funds and Business Development Companies. Destra Capital Investments, LLC serves as Distributor for all Destra Mutual Funds and Meridian Mutual Funds. Destra also acts as the secondary market servicing agent for all the Closed-End Funds listed below. Additional information on each product can be found by clicking the link on each respective product.

Important note: by clicking on a link to a non-Destra branded product, you will be leaving DestraCapital.com.

Quarterly

as of 9.30.16

fund name ticker 3 MO YTD 1YR 3YR 5YR from
incep.
distribution
Mutual Funds    
Destra Focused Equity
Inception Date: April 12, 2011
DFOAX A at NAV 0.58 -5.51 -2.33 5.52 11.14 8.38 annually
DFOAX A -3.95 -9.75 -6.72 3.91 10.11 7.47 annually
DFOIX I 0.62 -5.32 -2.03 5.85 11.50 8.74 annually
DFOCX C -0.65 -7.02 -4.00 4.73 n/a 8.30 annually
Destra Flaherty & Crumrine Preferred and Income
Inception Date: April 12, 2011
DPIAX A at NAV 3.60 8.36 10.84 9.20 9.01 8.24 monthly
DPIAX A -1.09 3.51 5.87 7.54 8.01 7.32 monthly
DPIIX I 3.68 8.60 11.30 9.63 9.41 8.62 monthly
DPICX C 2.39 6.77 9.03 8.42 n/a 7.91 monthly
Destra Dividend Total Return
Inception Date: August 10, 2011
DHDAX A at NAV 1.89 8.66 10.89 4.29 9.54 9.47 quarterly
DHDAX A -2.70 3.76 5.91 2.70 8.54 8.49 quarterly
DHDIX I 1.90 8.86 11.24 4.62 9.92 9.84 quarterly
DHDCX C 0.68 7.00 9.08 3.52 n/a 6.87 quarterly
Destra Wolverine Alternative Opportunities
Inception Date: October 7, 2015
DWAAX A at NAV 0.99 3.97 n/a n/a n/a 2.27 annually
DWAAX A -3.59 -0.68 n/a n/a n/a -2.32 annually
DWAIX I 0.99 4.08 n/a n/a n/a 2.53 annually
DWACX C -0.30 2.26 n/a n/a n/a 0.46 annually
Meridian Growth
Inception Date: August 1, 1984
MRAGX A 7.67 14.52 17.79 8.03 13.89 11.67 annually
MRCGX C 7.45 13.89 17.06 7.44 13.27 11.06 annually
MRIGX Investor 7.70 14.69 18.15 8.43 14.25 11.96 annually
Meridian Contrarian
Inception Date: February 10, 1994
MFCAX A 9.99 11.23 16.28 7.25 15.84 12.59 annually
MFCCX C 9.85 10.85 15.83 6.79 14.63 12.09 annually
MFCIX Investor 9.72 10.39 15.17 6.15 14.63 11.39 annually
Meridian Equity Income
Inception Date: January 31, 2005
MRAEX A 7.54 8.67 12.59 6.79 12.30 5.94 annually
MRCEX C 7.48 8.34 12.14 6.35 12.10 5.97 annually
MRIEX Investor 7.59 8.90 12.92 7.04 12.57 6.20 annually
Meridian Small Cap Growth
Inception Date: December 15, 2013
MSGAX A 11.22 16.99 17.66 n/a n/a 11.75 annually
MSGCX C 11.07 16.43 16.98 n/a n/a 10.98 annually
MISGX Investor 11.39 17.33 18.09 n/a n/a 12.11 annually
Closed-End Funds    
Ares Dynamic Credit Allocation Fund
Inception Date: November 27, 2012
ARDC Market 10.34 19.46 17.19 2.20 n/a 0.54 monthly
XADCX NAV 8.03 15.58 9.58 3.54 n/a 4.49 monthly
Flaherty & Crumrine Dynamic Preferred and Income
Inception Date: May 24, 2013
DFP Market 5.78 16.74 21.99 15.03 n/a 8.81 monthly
XDFPX NAV 5.75 12.10 14.58 13.21 n/a 10.37 monthly
Flaherty & Crumrine Preferred Securities Income Fund
Inception Date: January 31, 2003
FFC Market -2.05 10.38 20.58 14.25 15.23 8.71 monthly
XFFCX NAV 4.20 10.47 12.52 11.78 13.79 8.17 monthly
Flaherty & Crumrine Total Return Fund
Inception Date: August 29, 2003
FLC Market -2.55 16.10 22.07 13.97 13.14 8.10 monthly
XFLCX NAV 4.13 9.81 11.94 11.36 13.11 7.87 monthly
Tekla Healthcare Investors
Inception Date: March 8, 1992
HQH Market 3.50 -14.40 -3.30 9.82 23.19 11.05 quarterly
XHQHX NAV 7.34 -13.37 -5.61 10.46 22.04 11.31 quarterly
Tekla Life Sciences Investors
Inception Date: April 23, 1987
HQL Market 8.96 -13.16 -4.27 10.00 24.38 9.48 quarterly
XHQLX NAV 13.24 -9.40 -2.17 11.00 23.26 9.33 quarterly
Tekla Healthcare Opportunities Fund
Inception Date: July 28, 2014
THQ Market 7.19 7.04 18.57 n/a n/a 1.82 monthly
XTHQX NAV 6.69 3.84 11.44 n/a n/a 7.71 monthly
Tekla World Healthcare Fund
Inception Date: June 26, 2015
THW Market 4.93 -4.38 5.26 n/a n/a -19.72 monthly
XTHWX NAV 4.77 -6.66 0.76 n/a n/a -5.56 monthly
RMR Real Estate Income Fund
Inception Date: December 18, 2003
RIF Market 3.17 18.46 28.72 15.65 18.76 4.47 annually
XRIFX NAV 1.44 18.29 26.20 16.05 17.56 4.06 annually

Monthly

as of 10.31.16

fund name ticker 3 MO YTD 1YR 3YR 5YR from
incep.
distribution
Mutual Funds    
Destra Focused Equity
Inception Date: April 12, 2011
DFOAX A at NAV -5.25 -7.82 -10.70 3.68 8.42 7.77 annually
DFOAX A -9.49 -11.96 -14.71 2.10 7.43 6.88 annually
DFOIX I -5.22 -7.60 -10.46 4.01 8.78 8.12 annually
DFOCX C -5.45 -8.39 -11.37 2.91 n/a 7.61 annually
Destra Flaherty & Crumrine Preferred and Income
Inception Date: April 12, 2011
DPIAX A at NAV 1.25 8.25 8.85 8.61 8.55 8.09 monthly
DPIAX A -3.29 3.41 3.93 6.96 7.56 7.19 monthly
DPIIX I 1.26 8.46 9.23 9.01 8.93 8.46 monthly
DPICX C 1.01 7.56 8.07 7.81 n/a 7.73 monthly
Destra Dividend Total Return
Inception Date: August 10, 2011
DHDAX A at NAV -3.38 6.16 0.46 2.42 7.04 8.82 quarterly
DHDAX A -7.74 1.37 -4.05 0.86 6.07 7.86 quarterly
DHDIX I -3.31 6.42 0.74 2.77 7.41 9.19 quarterly
DHDCX C -3.56 5.45 -0.31 1.66 n/a 6.25 quarterly
Destra Wolverine Alternative Opportunities
Inception Date: October 7, 2015
DWAAX A at NAV -3.09 2.04 -0.82 n/a n/a 0.34 annually
DWAAX A -7.48 -2.53 -5.31 n/a n/a -3.89 annually
DWAIX I -3.00 2.24 -0.47 n/a n/a 0.68 annually
DWACX C -3.31 1.33 -1.53 n/a n/a -0.42 annually
Meridian Growth
Inception Date: August 1, 1984
MRAGX A -3.83 8.09 6.34 5.33 9.59 11.44 annually
MRCGX C -4.01 7.46 5.65 4.75 8.99 10.83 annually
MRIGX Investor -3.79 8.30 6.65 5.72 9.94 11.73 annually
Meridian Contrarian
Inception Date: February 10, 1994
MFCAX A 0.21 7.61 5.00 4.70 11.07 11.90 annually
MFCCX C 0.09 7.12 4.41 4.07 11.07 11.20 annually
MFCIX Investor 0.29 7.88 5.30 4.97 12.04 12.18 annually
Meridian Equity Income
Inception Date: January 31, 2005
MRAEX A 0.25 5.96 1.64 4.21 9.56 5.67 annually
MRCEX C 0.17 5.64 1.22 3.76 9.35 5.70 annually
MRIEX Investor 0.25 6.20 1.80 4.46 9.82 5.94 annually
Meridian Small Cap Growth
Inception Date: December 15, 2013
MSGAX A -0.16 11.18 9.01 n/a n/a 9.42 annually
MSGCX C -0.32 10.54 8.29 n/a n/a 8.66 annually
MISGX Investor -0.16 11.47 9.30 n/a n/a 9.75 annually
Closed-End Funds    
Ares Dynamic Credit Allocation Fund
Inception Date: November 27, 2012
ARDC Market 4.05 19.08 12.65 1.98 n/a 0.45 monthly
XADCX NAV 4.16 16.62 9.03 3.39 n/a 4.62 monthly
Flaherty & Crumrine Dynamic Preferred and Income
Inception Date: May 24, 2013
DFP Market 0.19 14.55 16.02 15.00 7.10 7.99 monthly
XDFPX NAV 2.10 12.10 12.21 12.17 0.00 10.10 monthly
Flaherty & Crumrine Preferred Securities Income Fund
Inception Date: January 31, 2003
FFC Market -4.42 8.11 12.06 12.70 12.90 8.49 monthly
XFFCX NAV 1.80 10.90 11.22 11.02 13.10 8.15 monthly
Flaherty & Crumrine Total Return Fund
Inception Date: August 29, 2003
FLC Market -1.75 16.30 18.69 13.36 12.58 8.06 monthly
XFLCX NAV 1.74 10.22 10.57 10.61 12.59 7.85 monthly
Tekla Healthcare Investors
Inception Date: March 8, 1992
HQH Market -18.00 -24.54 -28.55 4.52 18.61 0.00 quarterly
XHQHX NAV -11.02 -21.14 -19.30 7.53 18.79 10.92 quarterly
Tekla Life Sciences Investors
Inception Date: April 23, 1987
HQL Market -12.17 -22.34 -26.05 6.39 20.29 8.95 quarterly
XHQLX NAV -7.38 -18.14 -16.31 8.25 19.52 8.84 quarterly
Tekla Healthcare Opportunities Fund
Inception Date: July 28, 2014
THQ Market -9.67 -4.32 -1.98 n/a n/a -3.18 monthly
XTHQX NAV -9.52 -5.29 -4.49 n/a n/a 3.12 monthly
Tekla World Healthcare Fund
Inception Date: June 26, 2015
THW Market -8.96 -11.35 -10.44 n/a n/a -23.05 monthly
XTHWX NAV -10.49 -14.96 -11.51 n/a n/a -11.54 monthly
RMR Real Estate Income Fund
Inception Date: December 18, 2003
RIF Market -9.90 9.20 11.21 10.40 15.55 3.78 annually
XRIFX NAV -9.80 11.40 11.80 12.29 13.93 3.55 annually

Data presented reflects past performance, which is no guarantee of future results. Investment results and principal value will fluctuate so that shares, when redeemed, may be worth more or less than their original cost. Due to market volatility, current performance may be higher or lower than the performance shown.

Mutual Fund Related Risks

Performance shown for Class A Shares with load includes the Fund’s maximum sales charge of 4.50% for the Dividend Total Return, Focused Equity and Alternative Opportunities, and the Flaherty & Crumrine Preferred and Income Funds. Returns include reinvestment of all distributions and returns of less than 1 year are not annualized.

For the Focused Equity Fund, the Adviser has agreed to cap expenses such that the total annual fund operating expenses, excluding brokerage commissions and other trading expenses, taxes, acquired fund fees and other extraordinary expenses (such as litigation and other expenses not incurred in the ordinary course of business) at 1.61% for Class A, 2.36% for Class C and 1.33% for Class I. This waiver will continue in effect until February 1, 2022. The waiver may be terminated or modified prior to February 1, 2022 only with the approval of the Board of Trustees of the Trust. The gross expenses for the Class A, Class C and Class I shares are 1.90%, 3.45% and 1.54% respectively.

For the Preferred and Income Fund, the Adviser has agreed to cap expenses such that the total annual fund operating expenses, excluding brokerage commissions and other trading expenses, taxes, acquired fund fees and other extraordinary expenses (such as litigation and other expenses not incurred in the ordinary course of business) at 1.50% for Class A, 2.25% for Class C and 1.22% for Class I. This waiver will continue in effect until February 1, 2022. The waiver may be terminated or modified prior to February 1, 2022 only with the approval of the Board of Trustees of the Trust. The gross expenses for the Class A, Class C and Class I shares are 1.99%, 3.09% and 1.55% respectively.

For the Dividend Total Return Fund, the Adviser has agreed to cap expenses such that the total annual fund operating expenses, excluding brokerage commissions and other trading expenses, taxes, acquired fund fees and other extraordinary expenses (such as litigation and other expenses not incurred in the ordinary course of business) at 1.61% for Class A, 2.36% for Class C and 1.33% for Class I. This waiver will continue in effect until February 1, 2022. The waiver may be terminated or modified prior to February 1, 2022 only with the approval of the Board of Trustees of the Trust. The gross expenses for the Class A, Class C and Class I shares are 2.13%, 2.82% and 1.80% respectively.

For the Alternative Opportunities Fund, the Adviser has agreed to cap expenses such that the total annual fund operating expenses, excluding brokerage commissions and other trading expenses, taxes, acquired fund fees and other extraordinary expenses (such as litigation and other expenses not incurred in the ordinary course of business) at 2.00% for Class A, 2.75% for Class C and 1.75% for Class I. This waiver will continue in effect until February 1, 2022. The waiver may be terminated or modified prior to February 1, 2022 only with the approval of the Board of Trustees of the Trust. The gross expenses for the Class A, Class C and Class I shares are 2.14%, 2.79% and 1.78% respectively.

Included in the each Fund’s Class A shares expenses is a distribution and service (12b-1) fee of 0.25%.

Included in the each Fund’s Class C shares expenses is a distribution and service (12b-1) fee of 1.00%.

Investing outside the United States involves additional risks, such as currency fluctuations, political instability risks, periods of illiquidity, and price volatility, as more fully described in the prospectus. These risks may be heightened in connection with investments in developing countries. Small company stocks entail additional risks, and they can fluctuate in price more than larger company stocks. The value of fixed-income securities may be affected by changing interest rates and changes in credit ratings of the securities. As interest rates rise, the prices of fixed-income securities generally fall. Lower rated bonds and preferred securities are subject to greater fluctuations in value and risk of loss of income and principal than higher rated bonds. For more information about the risks associated with each fund, go to its detailed fund information page or read the prospectus.

Some important risks of the Focused Equity Fund are: market risk, securities selection risk, sector focus risk, non-diversification/limited holdings risk, investment strategy risk and investment risk.

Some important risks of the Preferred and Income Fund are: market risk, preferred and subordinated security risk, credit risk, interest rate risk, high-yield securities risk, liquidity risk, non-u.s. investment risk, non-diversification risk, securities selection risk, investment risk and issuer concentration in industries with regulated capital structure.

Some important risks of the Dividend Total Return Fund are: dividend income risk, foreign investment risk/emerging markets risk, depositary receipts risk, currency risk, master limited partnership risk and sector risk, energy companies risk, health care companies risk, convertible securities risks and derivatives risk.

Some important risks of the Wolverine Alternative Opportunities Fund are: call risk, clearing broker risk, commodities risk, counterparty risk, credit risk, currency risk, derivatives risk, equity securities risk, ETF risk, Europe investment risk, foreign commodity markets risk, frequent trading risk, futures risk, gap risk, general fund investing risks, high yield securities risk, income risk, interest rate risk, japan investment risk, liquidity risk, new fund risk, options risk, real estate investment risk, regulatory risk, smaller companies risk, subsidiary investment risk, swap agreements risk, tax risk, volatility risk and whipsaw markets risk.

Closed-End Fund Related Risks

Performance data quoted represents past performance, which is no guarantee of future results, and current performance may be lower or higher than the figures shown. The NAV total return takes into account the Fund’s total annual expenses and does not reflect transaction charges. All distributions are assumed to be reinvested either in accordance with the dividend reinvestment plan (DRIP) for market price returns or NAV for NAV returns. Until the DRIP price is available from the Plan Agent, the market price returns reflect the reinvestment at the closing market price on the last business day of the month. Once the DRIP is available around mid-month, the market price returns are updated to reflect reinvestment at the DRIP price.

This information does not represent an offer to sell securities of the Funds nor is it soliciting an offer to buy securities of the Funds. There can be no assurance that the Funds will achieve their investment objectives. The value of the Funds will fluctuate with the value of the underlying securities. Historically, closed-end funds often
trade at a discount to their net asset value. Both the net asset value and the market value of shares of common stock may be subject to high volatility and a decline
in value.

Destra Capital Investments is providing secondary market servicing for the the Ares Dynamic Credit Allocation Fund, the Flaherty & Crumrine Dynamic Preferred and Income Fund, the Flaherty & Crumrine Preferred Securities Income Fund, the Flaherty & Crumrine Total Return Fund, the Tekla Healthcare Investors Fund, the Tekla Life Sciences Investors Fund, the Tekla Healthcare Opportunities Fund, the Tekla World Healthcare Fund, the RMR Real Estate Income Fund and Ares Capital Corporation.

Investing in the market is subject to risk and possible loss of principal amount invested.

Data provided by Destra Capital Investments unless otherwise noted.

Investors should consider the investment objective and policies, risk considerations, charges and ongoing expenses of an investment carefully before investing. The prospectus and summary prospectus contains this and other information relevant to an investment in the fund. Please read the prospectus or summary prospectus carefully before you invest or send money. To obtain a prospectus, please contact your investment representative or Destra Capital Investments LLC at 877.287.9646 or access our literature page.